Research Article

Differences in cNOS/iNOS Activity during Resistance to Trypanosoma cruzi Infection in 5-Lipoxygenase Knockout Mice

Figure 9

Plasma levels of PGE2. (a) Wild-type (129 WT mice) and 5-LO-/- mice uninfected and infected and (b) treated or untreated with NOS inhibitors. AG: infected mice treated with aminoguanidine (50 mg/kg/day i.p.); LN: infected mice treated with L-NAME (LN; 20 mg/kg/day i.p.); AG+LN: infected mice treated with aminoguanidine (50 mg/kg/day i.p. plus L-NAME 20 mg/kg/day). Mice were infected with trypomastigote forms of T. cruzi (Y strain). animals in each group and values are the . compared with the control group.
(a)
(b)